Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Magnesium (mg) retention and mood effects after intravenous mg infusion in premenstrual dysphoric disorder.

Khine K, Rosenstein DL, Elin RJ, Niemela JE, Schmidt PJ, Rubinow DR.

Biol Psychiatry. 2006 Feb 15;59(4):327-33. Epub 2005 Sep 28.

2.

A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder.

Rapkin A.

Psychoneuroendocrinology. 2003 Aug;28 Suppl 3:39-53. Review.

PMID:
12892989
3.

Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Steiner M.

J Psychiatry Neurosci. 2000 Nov;25(5):459-68. Review.

4.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein AA, Helmerhorst FM.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD006586. doi: 10.1002/14651858.CD006586.pub4. Review.

PMID:
22336820
5.

Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.

Luisi AF, Pawasauskas JE.

Pharmacotherapy. 2003 Sep;23(9):1131-40. Review.

PMID:
14524645
6.

Fluoxetine in the treatment of premenstrual dysphoric disorder.

Carr RR, Ensom MH.

Ann Pharmacother. 2002 Apr;36(4):713-7. Review.

PMID:
11918525
7.

The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).

Halbreich U, Borenstein J, Pearlstein T, Kahn LS.

Psychoneuroendocrinology. 2003 Aug;28 Suppl 3:1-23. Review.

PMID:
12892987
8.

The association between premenstrual dysphoric disorder and other mood disorders.

Yonkers KA.

J Clin Psychiatry. 1997;58 Suppl 15:19-25. Review.

PMID:
9427873
9.

Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder.

Frackiewicz EJ, Shiovitz TM.

J Am Pharm Assoc (Wash). 2001 May-Jun;41(3):437-47. Review.

PMID:
11372908
10.

SSRIs for premenstrual dysphoric disorder.

[No authors listed]

Drug Ther Bull. 2002 Sep;40(9):70-2. Review.

PMID:
12298224
11.

Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.

Silber TJ, Valadez-Meltzer A.

J Adolesc Health. 2005 Dec;37(6):518-25. Review.

PMID:
16310133
12.

Treatment of premenstrual dysphoric disorder.

Rapkin AJ, Lewis EI.

Womens Health (Lond). 2013 Nov;9(6):537-56. doi: 10.2217/whe.13.62. Review.

PMID:
24161307
13.

Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder.

Freeman EW.

Pharmacoeconomics. 2005;23(5):433-44. Review.

PMID:
15896095
14.

Selective serotonin reuptake inhibitors for premenstrual syndrome.

Brown J, O' Brien PM, Marjoribanks J, Wyatt K.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001396. doi: 10.1002/14651858.CD001396.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD001396.

PMID:
19370564
15.

Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder.

Freeman EW.

Curr Psychiatry Rep. 2002 Dec;4(6):435-40. Review.

PMID:
12441023
16.

Selective serotonin reuptake inhibitors for premenstrual syndrome.

Marjoribanks J, Brown J, O'Brien PM, Wyatt K.

Cochrane Database Syst Rev. 2013 Jun 7;(6):CD001396. doi: 10.1002/14651858.CD001396.pub3. Review.

PMID:
23744611
17.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein AA, Helmerhorst FM.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006586. doi: 10.1002/14651858.CD006586.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD006586.

PMID:
19370644
18.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein A, Helmerhorst FM.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006586. doi: 10.1002/14651858.CD006586.pub2. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD006586.

PMID:
18254106
19.

Diagnosis and treatment of premenstrual dysphoric disorder: an update.

Steiner M, Born L.

Int Clin Psychopharmacol. 2000 Nov;15 Suppl 3:S5-17. Review.

PMID:
11195269
20.

Update on research and treatment of premenstrual dysphoric disorder.

Cunningham J, Yonkers KA, O'Brien S, Eriksson E.

Harv Rev Psychiatry. 2009;17(2):120-37. doi: 10.1080/10673220902891836. Review.

Supplemental Content

Support Center